Quality by design: A lifecycle concept for pharmaceutical analysis

European Pharmaceutical Review

Volumn 16, Issue 3, 2011, Pages 16-24

  Ermer, Joachim ^a  

^a Sanofi ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANALYTICAL TARGET PROFILE; CHANGE MANAGEMENT; DRUG MANUFACTURE; INFORMATION; MATHEMATICAL COMPUTING; MEASUREMENT ERROR; PRACTICE GUIDELINE; PROCESS CONTROL; PROCESS DESIGN; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCT DEVELOPMENT; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; VALIDATION PROCESS;

EID: 82755165373     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (20)

1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) http://www.ich.org/products/ guidelines/quality/article/quality-guidelines.html ICH Q8 (R2): Pharmaceutical Development (2009)
2. ICH Q9: Quality Risk Management (2005)
3. ICH Q10: Pharmaceutical Quality System (2008)
4. ICH Q11: Development and Manufacture of Drug Substances (chemical entities and biotechnological/biological entities) Draft Pre Step 2 (2010)10
5. P. Borman, P. Nethercote, M. Chatfield, D. Thompson, K. Truman, The Application of Quality by Design to Analytical Methods. Pharmaceutical Technology, October 2007, 142-152
6. P.F. Gavin, B.A. Olsen, A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). J.Pharm.Biomed.Anal. 46 (2008) 431-41
7. M. Schweitzer, M. Pohl, Implications and Opportunities of Applying QbD Principles to Analytical Measurements. Pharmaceutical Technology, Feb. 2010, 2-8 http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id=654746
8. European Medicines Agency: Compliance and Inspection Report: Results of the Sampling and Testing Programme for the year 2009. (Nov. 2010) EMA/INS/S&T/477571/2010 http://www.ema.europa.eu/docs/en-GB/document- library/Report/2010/08/WC500095740.pdf
9. ICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology (2005)
10. United States Pharmacopeia, Section 〈1010〉 'Analytical Data - Interpretation and Treatment
11. Consensus paper of the Working Group Quality Control/Pharmaceutical Analysis of the German Pharmaceutical Society (DPhG); http://www.pharmchem.tu- bs.de/forschung/waetzig/englisch/dphg-pospapier-eng03.pdf
12. EURACHEM/CITAC Guide: Quantifying uncertainty in analytical measurement. 2nd edition. 2000. http://www.measurementuncertainty.org
13. D. Huffman, R. Kringle, A total error approach for the validation of quantitative analytical methods. Pharm.Res. 24 (2007) 1157-64 (Pubitemid 46798895)
14. J. Ermer: Chapter 2.3 Accuracy in: J. Ermer, J.H.McB. Miller (Eds.) Method Validation in Pharmaceutical Analysis. A Guide to Best Practice. Wiley VCH, Weinheim (2005) 77-79
15. J.B. Crowther, M.I. Jimidar, N. Niemeijer, P. Salomons: Chapter 15 in: J.M. Miller, J.B. Crowther, eds.: Analytical chemistry in a GMP environment. John Wiley, New York (2000) 448-9
16. European Pharmacopoeia: Technical Guide for the elaboration of monographs, 5th Edition (2010)
17. ISO 5725-2, Basic method for the determination of repeatability and reproducibility of a standard measurement method (1994)
18. J. Ermer et al., Precision from drug stability studies. Investigation of reliable repeatability and intermediate precision of HPLC assay procedures. J. Pharm. Biomed. Anal. 38/4 (2005) 653-663 (Pubitemid 40835563)
19. European Medicines Agency, GUIDELINE ON THE USE OF NEAR INFRARED SPECTROSCOPY BY THE PHARMACEUTICAL INDUSTRY AND THE DATA REQUIREMENTS FOR NEW SUBMISSIONS AND VARIATIONS (Draft) Feb. 2009
20. United States Pharmacopeia, General Chapter on Inorganic Impurities: Heavy Metals (Draft http://www.usp.org/pdf/EN/USPNF/2008-04- 10InorganicImpuritiesStim.pdf